Laupacis, A. (2018) “Evidence and Values: Requirements for Public Reimbursement of Drugs for Rare Diseases- A Case Study in Oncology- Reply”, Journal of Population Therapeutics and Clinical Pharmacology, 16(2). Available at: https://mail.jptcp.com/index.php/jptcp/article/view/557 (Accessed: 19 November 2024).